Proceedings: Anticoagulation during six hours of extracorporeal perfusion. Comparison between heparinization and defibrinogenation.
D000818:Animals; D012103:Batroxobin / Q000627:therapeutic use*; D004285:Dogs; D005112:Extracorporeal Circulation; D006493:Heparin / Q000627:therapeutic use*; D010107:Oxygenators, Membrane; D010447:Peptide Hydrolases / Q000627:therapeutic use*
D006493:Heparin; D010447:Peptide Hydrolases; D012103:Batroxobin